Human Genome Sciences Inc. (HGSI) Reports Q1 EPS Loss of $0.69
Tweet
Share
E-mailGet Alerts HGSI Hot Sheet
Price: $14.24 --0%
Financial Fact:
Cost of manufacturing and development services: 21.77M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Cost of manufacturing and development services: 21.77M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Human Genome Sciences Inc. (NASDAQ: HGSI) reported Q1 EPS of ($0.69), $0.21 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $26.6 million versus the consensus estimate of $19.26 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
